While the current MDL in the Eastern District of Pennsylvania centers on gastrointestinal injuries, the growing number of NAION-related claims has raised the question of whether the MDL may eventually expand to include additional categories of injury
And the use of food to support GLP-1 minimizes the potential adverse side effects that typically come with GLP-1 medications
Role of GLP-1 Receptor Agonists for Weight Loss Key studies including the SCALE and STEP trials are highlighted and the efficacy of the GLP-1 receptor agonists liraglutide and
While early findings have generated interest, more evidence is needed to understand its long-term effectiveness, safety and potential role in future treatment
Pepscience should only be used under the guidance of a licensed healthcare professional
M.H., S.V.P., M.D.T.T., C.d.l.F.-N., and Y.A., wrote the manuscript